$UTI

Grant Jerome Alan sold $3.9M of UTI

Grant Jerome Alan (Chief Executive Officer) sold 94,500 shares of UNIVERSAL TECHNICAL INSTITUTE INC (UTI) at an average of $41.40 ($41.15–$41.63, $3.91M total) across 2 trades on 2026-06-29.

Original reporting
SEC EDGAR · Grant Jerome Alan
Published Jul 1, 2026, 12:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 1, 2026, 12:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$UTI
Neutral
medium confidence
Mentioned
$UTI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$UTINeutralLow
01

Why it matters

Traders may monitor for follow-on insider activity or other disclosures, but this text alone does not introduce new operating or financial information.

02

Market read

A primary-source insider sale totaling ~$3.91M is disclosed, which can influence short-term sentiment but lacks fundamental catalysts.

03

What to watch

The filing states no pre-arranged 10b5-1 plan, which can increase scrutiny, but the article provides no stated reason for the sale or any accompanying operational news.

Relevance 6/10Novelty 5/10Timing: immediately after the 2026-06-29 insider sale; filed 2026-06-30 after market close

Background

The article is an SEC Form 4 insider transaction: CEO Grant Jerome Alan sold shares of Universal Technical Institute Inc.

Company-level read

Ticker impact

$UTINeutralMedium confidence
Context

SEC Form 4 shows CEO Grant Jerome Alan sold 94,500 shares of UTI for about $3.91M on 2026-06-29.

Expected impact

Likely limited near-term price impact; any effect is sentiment-driven and typically fades unless repeated or paired with other disclosures.

Evidence & confidence

The filing is primary-source and time-stamped, but it provides no new company performance, guidance, or deal information; also notes no 10b5-1 plan.

Market effects

No sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Insider sales can be routine liquidity events; the disclosed sale size may not imply bearish expectations without additional context.

Key entities

  • Universal Technical Institute Inc

    Issuer of the Form 4 insider sale by its CEO.

  • Grant Jerome Alan

    CEO and officer/director who sold 94,500 shares in two trades on 2026-06-29.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$UTIMed

UTI Expands Credit Facility to $200 Million in New Five

Universal Technical Institute (UTI) secured a new $200M revolving credit facility, up from $125M, with a five-year term. The facility, led by Fifth Third Bank, includes a $75M letter of credit sublimit and a $75M incremental facility option. UTI plans to use the funds for working capital, internal initiatives, and potential acquisitions. The expanded lending syndicate suggests increased institutional confidence in UTI's growth strategy.

$UTIMed

Universal Technical Institute Secures $200 Million Revolving Credit Facility, Maturing 2031

Universal Technical Institute (UTI) secured a $200 million revolving credit facility maturing in 2031, refinancing its prior agreement and bolstering liquidity. The facility, arranged by Fifth Third Bank, includes a $15 million swingline, a $75 million letter-of-credit sublimit, and up to $75 million of uncommitted incremental capacity. Borrowings bear interest at Term SOFR plus 1.50%–2.25% or Base Rate plus 0.50%–1.25%, with an unused fee of 0.20%–0.35%. The company also executed a Guaranty and

$UTIMedAI 8/10

Universal Technical Institute Q3 Earnings Call Highlights

Universal Technical Institute (NYSE:UTI) reported Q3 revenue of $138 million, up 5%, and Concorde revenue of $80.9 million, up 11.1%. Management cited employer shortages and said high school automotive and diesel starts were below expectations due to admissions execution. FY2026 guidance: revenue $893m-$900m, net income $32m-$36m, EPS $0.57-$0.64, baseline adj. EBITDA >$135m.

$UTIMed

UNIVERSAL TECHNICAL INSTITUTE INC (UTI): Results of Operations and Financial Condition

UNIVERSAL TECHNICAL INSTITUTE INC (UTI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Universal Technical Institute Reports Fiscal Year 2026 Third Quarter Results Total New Student Start Growth Exceeded Expectations Driven by Strong Demand and Continued Momentum Across New Campuses, Reinforcing Confidence in Long-Term North Star Targets PHOENIX, ARIZ.

$UTIMedAI 8/10

UTI Asset Management Company Limited Reports Q1 FY27 Results; Consolidated Total Income Up 6.7% YoY to ₹585 Crore; Total Group AUM Crosses ₹20.56 Lakh Crore

UTI Asset Management Company Limited (UTI AMC) reported unaudited Q1 FY27 results for the quarter ended June 30, 2026. Consolidated total income rose 6.7% YoY to ₹585.23 crore, with consolidated PAT attributable to owners up 24.1% YoY to ₹293.86 crore. Group AUM crossed ₹20.56 lakh crore and live folios reached 1.42 crore, with SIP inflows of ₹2,502 crore. Source: Equity Bulls.